Related Experiment Video
Updated: Jan 6, 2026

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
Published on: June 4, 2021
F-Site: Recognizing Fluorination Patterns in Small-Molecule Drugs via a Two-Stage Transformer-Based Model
Yichu Wu1, Xiang Lian1,2, Shuai Tao1
1Faculty of Chemical Engineering and Energy Technology, Shanghai Institute of Technology, Shanghai 201418, China.
Abstract:
Fluorination is a powerful strategy for modulating drug properties. However, accurately identifying suitable fluorination sites and introducing appropriate fluorinated groups into organic molecules remain significant challenges, often relying on chemical intuition and iterative experimentation. To address this gap, we developed F-site, a transformer-based Seq2Seq framework trained on a large, structurally nonredundant data set of preclinical fluorinated compounds curated from ChEMBL. The model achieved over 98% token-level accuracy on internal validation, demonstrating robust learning of molecular sequence patterns. Notably, on a nonredundant independent test set of clinical-stage and approved fluorinated drugs, F-site recovered the validated fluorination patterns in approximately 80% of cases within the top-ranked candidates for a given input scaffold. This result highlights the model's capability to generate compact and highly relevant sets of modification hypotheses. In summary, this performance underscores the F-site model's potential to substantially narrow the experimental search space for fluorination design in small molecules, thereby providing an efficient computational tool to guide fluorination strategies in early-stage drug discovery.
More Related Videos
09:24Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
09:04Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
Published on: April 18, 2019